Status:
UNKNOWN
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
Lead Sponsor:
University Hospital, Brest
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
7+ years
Brief Summary
An increase in the prevalence of infections due to non-tuberculous mycobacteria (NTM) is observed in many countries and recent data suggest the circulation of dominant clones with a possibility of hum...
Detailed Description
Non-tuberculous mycobacteria (NTM) are important new pathogens in cystic fibrosis, with prevalence estimates ranging from 6% to 13%. The diagnosis of the disease in cystic fibrosis patients is difficu...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype
- Affiliation to the social security system
- Patients able to expectorate spontaneously
- Patients enrolled in the French Register of Cystic Fibrosis
- Minor or major patients of expectorant age
- Consent signed by the patient or the holder of parental authority for the children
Exclusion
- Patient not registered in the French Register of Cystic Fibrosis
- Pulmonary transplant patients
- Persons deprived of liberty, persons under guardianship or curatorship, persons in emergency situations
- Person not affiliated to a social security system or not entitled
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03312075
Start Date
January 1 2018
End Date
January 1 2022
Last Update
January 4 2018
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80054
2
CHRU Brest
Brest, France, 29200
3
CHU Côte de Nacre
Caen, France, 14033
4
CHIC Créteil
Créteil, France, 94000